-
Published 8/19/2025
Huang J, Wang Y, Stein TD, Ang TFA, Zhu Y, Tao Q, Lunetta KL, Mez J, Au R, Farrer LA, Qiu WQ, Zhang X. The impact of blood MCP-1 levels on Alzheimer's disease with genetic variation at the NAV3 and UNC5C loci. Transl Psychiatry. 2025 Aug 19; 15(1):296. PMID: 40830334.
-
Published 4/19/2025
Yuan J, Tao Q, Au R. Reply to "Gender Differences and Vascular Risk: Unveiling New Pathways for Dementia Prevention". Ann Neurol. 2025 Jun; 97(6):1224-1225. PMID: 40251898.
-
Published 3/1/2025
Rehman H, Ang TFA, Tao Q, Au R, Farrer LA, Qiu WQ, Zhang X. Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study. Alzheimers Dement. 2025 Mar; 21(3):e70066. PMID: 40156298.
-
Published 10/15/2024
Yuan J, Tao Q, Ang TFA, Liu C, Devine S, Auerbach SH, Mez J, Farrer LA, Qiu WQ, Au R. The Relationship between Framingham Stroke Risk Profile on Incident Dementia and Alzheimer's Disease: A 40-Year Follow-Up Study Highlighting Female Vulnerability. Ann Neurol. 2024 Dec; 96(6):1124-1134. PMID: 39404028.
-
Published 10/1/2024
van Gils V, Tao Q, Ang TFA, Young CB, Mormino EC, Qiu WQ, Visser PJ, Au R, Jansen WJ, Vos SJB. Associations Between Glucose Metabolism Measures and Amyloid-ß and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study. Diabetes Care. 2024 Oct 01; 47(10):1787-1793. PMID: 39078159.